NTV Asset Management’s Pfizer PFE Stock Holding History

NTV Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$833K	Sell	29,670 -4,792	-14%	-$128K	0.09%	162
2025 Q4	$858K	Sell	34,462 -8,611	-20%	-$217K	0.09%	157
2025 Q3	$1.1M	Sell	43,073 -3,518	-8%	-$86.8K	0.12%	135
2025 Q2	$1.13M	Sell	46,591 -10,644	-19%	-$248K	0.14%	125
2025 Q1	$1.45M	Sell	57,235 -787	-1%	-$20.6K	0.19%	104
2024 Q4	$1.54M	Sell	58,022 -8,407	-13%	-$228K	0.2%	99
2024 Q3	$1.92M	Buy	66,429 +1,505	+2%	+$43.9K	0.26%	85
2024 Q2	$1.82M	Sell	64,924 -1,851	-3%	-$51K	0.26%	83
2024 Q1	$1.85M	Buy	66,775 +1,781	+3%	+$49.4K	0.28%	76
2023 Q4	$1.87M	Sell	64,994 -3,530	-5%	-$107K	0.32%	68
2023 Q3	$2.27M	Sell	68,524 -5,152	-7%	-$182K	0.41%	60
2023 Q2	$2.7M	Sell	73,676 -3,069	-4%	-$119K	0.47%	54
2023 Q1	$3.13M	Sell	76,745 -1,100	-1%	-$47.5K	0.58%	47
2022 Q4	$3.99M	Sell	77,845 -500	-0.6%	-$24K	0.78%	36
2022 Q3	$3.43M	Sell	78,345 -60	-0.1%	-$2.92K	0.72%	40
2022 Q2	$4.11M	Sell	78,405 -300	-0.4%	-$15.3K	0.8%	33
2022 Q1	$4.08M	Sell	78,705 -540	-0.7%	-$28K	0.68%	43
2021 Q4	$4.68M	Sell	79,245 -2,560	-3%	-$127K	0.78%	40
2021 Q3	$3.52M	Buy	81,805 +2,338	+3%	+$104K	0.61%	49
2021 Q2	$3.11M	Sell	79,467 -2,544	-3%	-$98.9K	0.55%	54
2021 Q1	$2.97M	Sell	82,011 -4,816	-6%	-$171K	0.55%	56
2020 Q4	$3.2M	Sell	86,827 -2,457	-3%	-$90.1K	0.64%	49
2020 Q3	$3.11M	Buy	89,284 +1,554	+2%	+$54.5K	0.74%	42
2020 Q2	$2.72M	Buy	87,730 +301	+0.3%	+$10.2K	0.7%	40
2020 Q1	$2.71M	Buy	87,429 +908	+1%	+$30.9K	0.89%	38
2019 Q4	$3.22M	Sell	86,521 -1,370	-2%	-$48.8K	0.82%	42
2019 Q3	$3M	Sell	87,891 -4,232	-5%	-$154K	0.85%	40
2019 Q2	$3.79M	Sell	92,123 -982	-1%	-$39K	1.09%	27
2019 Q1	$3.75M	Sell	93,105 -4,733	-5%	-$190K	1.07%	30
2018 Q4	$4.05M	Sell	97,838 -4,048	-4%	-$168K	1.31%	18
2018 Q3	$4.26M	Buy	101,886 +669	+0.7%	+$25.8K	1.15%	24
2018 Q2	$3.48M	Sell	101,217 -4,520	-4%	-$154K	0.98%	30
2018 Q1	$3.56M	Buy	105,737 +50	+0%	+$1.72K	1.01%	30
2017 Q4	$3.63M	Sell	105,687 -1,684	-2%	-$57.4K	1.01%	33
2017 Q3	$3.64M	Sell	107,371 -841	-0.8%	-$27K	1.05%	31
2017 Q2	$3.45M	Buy	108,212 +582	+0.5%	+$18.4K	1.05%	30
2017 Q1	$3.49M	Buy	107,630 +2,321	+2%	+$73.2K	1.11%	27
2016 Q4	$3.25M	Sell	105,309 -314	-0.3%	-$9.59K	1.12%	27
2016 Q3	$3.39M	Buy	105,623 +1	+0%	+$33	1.22%	25
2016 Q2	$3.53M	Sell	105,622 -1,205	-1%	-$38.5K	1.34%	23
2016 Q1	$3M	Buy	106,827 +67,721	+173%	+$1.93M	1.15%	25
2015 Q4	$1.2M	Sell	39,106 -14,175	-27%	-$446K	0.47%	63
2015 Q3	$1.59M	Sell	53,281 -304	-0.6%	-$9.75K	0.52%	58
2015 Q2	$1.7M	Sell	53,585 -22	-0%	-$717	0.5%	62
2015 Q1	$1.77M	Sell	53,607 -1,525	-3%	-$48.5K	0.53%	59
2014 Q4	$1.63M	Buy	55,132 +637	+1%	+$18.3K	0.48%	68
2014 Q3	$1.53M	Buy	54,495 +2,014	+4%	+$56.5K	0.46%	67
2014 Q2	$1.48M	Buy	52,481 +472	+0.9%	+$13.5K	0.45%	70
2014 Q1	$1.58M	Buy	52,009 +2,639	+5%	+$78.7K	0.51%	66
2013 Q4	$1.43M	Buy	49,370 +3	+0%	+$87	0.49%	66
2013 Q3	$1.34M	Buy	49,367 +3	+0%	+$82	0.47%	70
2013 Q2	$1.31M	Buy	+49,364	New	+$1.36M	0.48%	64

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

NTV Asset Management's PFE Position: Q1 2026 in Review

NTV Asset Management reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $128K and leaving 29,670 shares worth $833K. The position accounts for 0.09% of the portfolio, ranked #162.

NTV Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.68M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

NTV Asset Management held 29,670 shares of Pfizer worth $833K as of Q1 2026.
NTV Asset Management sold 4,792 Pfizer shares in Q1 2026, an estimated $128K.
Pfizer made up 0.09% of NTV Asset Management's portfolio in Q1 2026, its #162 holding.
NTV Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
NTV Asset Management's Pfizer position peaked at $4.68M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.